Fengling Luo, Ph.D.

E-mail Address: fengling810810@163.com

Office Address: 185# DongHu Road, Wuhan, Hubei, 430071

Position(s): Lecturer

Affiliation(s): Department of Immunology

Research interests / Specialties:

Infection and Immunity

Education and Training

1998-2003, B.M. Wuhan University School of Medicine, Wuhan,

People’s Republic of China.

2003-2008, Ph.D. Wuhan University School of Medicine, Wuhan,

People’s Republic of China.

2013-2014, Postdoctor. University of Louisville, USA.

Research Description

My research investigate focus on the molecular mechanism of MTB

Publication list

1. Luo F, Sun X, Wang Y, Wang Q, Wu Y, Pan Q, Fang C, Zhang XL*. Ficolin-2 defends against virulent Mycobacteria tuberculosis infection in vivo, and its insufficiency is associated with infection in humans. PLoS One. 8(9):e73859, 2013.

2. Deng M, Feng S, Luo F, Wang S, Sun X, Zhou X*, Zhang XL*. Visual detection of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis using an asymmetrically split peroxidase DNAzyme. J. Clin. Microbiol. 50: 3443-3450, 2012 (co-first author).

3. Hu YL, Luo F, Fu JL, Chen TL, Wu SM, Zhou YD, Zhang XL*.Early increased ficolin-2 concentrations are associated with severity of liver inflammation and efficacy of anti-viral therapy in chronic hepatitis C patients. Scand. J. Immunol. 77(2):144-150,2013. (co-first author).

4. Liu M, Pan Q, Luo FL, Meyers C, Zhang XL*, Tumor carbohydrate antigens and strategies to develop cancer vaccines and drugs, Wuhan University Journal of Natural Sciences, 18(1), 1-8, 2013. (co-first author).

5. Pan Q, Wang Q, Sun X, Xia X, Wu S, Luo F，Zhang XL*, Aptamer against mannose-capped lipoarabinomannan inhibits virulent Mycobacterium tuberculosis infection in mice and rhesus monkeys, Mol Ther. 22(5):940-951, 2014. (IF:7.1).